CYTOSORBENTS CORP (CTSO) Stock Cash Flow
NASDAQ:CTSO - Nasdaq - US23283X2062 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.84M | -20.72M | -28.51M | -32.81M | -24.56M | |||
| Depreciation Amortization | 1.75M | 1.74M | 1.46M | 880.00K | 730.00K | |||
| Change In Working Capital | -3.40M | -4.38M | 2.36M | -3.56M | 640.00K | |||
| Interest Paid | 1.60M | 1.29M | 376.70K | 0.00 | 0.00 | |||
| Other non cash items | 4.42M | 8.93M | 3.03M | 7.26M | 9.18M | |||
| OPERATING CASH FLOW | -13.06M | -14.43M | -21.66M | -28.23M | -14.01M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -589.60K | -669.40K | -936.20K | -6.46M | -4.28M | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -589.60K | -669.40K | -936.20K | -6.46M | -4.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 10.63M | 10.00M | 0.00 | 5.00M | 0.00 | |||
| Stock Issued/Repurchased | 6.96M | 178.70K | 14.47M | -40.00K | 720.00K | |||
| Other Financing Activity | N/A | -848.00K | N/A | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 16.73M | 9.33M | 14.47M | 4.96M | 720.00K | |||
| Exchange Rate Effect | -64.60K | -84.70K | -99.80K | -260.00K | -20.00K | |||
| CHANGE IN CASH | 3.02M | -5.85M | -8.22M | -29.99M | -17.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.06M | -14.43M | -21.66M | -28.23M | -14.01M | |||
| Capital Expenditure | -589.60K | -669.40K | -936.20K | -6.46M | -4.28M | |||
| FREE CASH FLOW | -13.65M | -15.10M | -22.59M | -34.69M | -18.29M | |||
All data in USD